Gsk Current Ratio Growth & History (GSK)

Gsk's current ratio was 0.82 for fiscal 2025.

View full Gsk company overview

Gsk annual current ratio history

Gsk annual current ratio

Fiscal yearPeriod endedCurrent ratioChangeGrowth
20252025-12-310.820.04+4.49%
20242024-12-310.78−0.10−11.48%
20232023-12-310.88−0.03−2.81%
20222022-12-310.910.12+15.41%
20212021-12-310.79−0.13−13.70%
20202020-12-310.910.10+12.80%
20192019-12-310.810.06+7.68%
20182018-12-310.750.15+25.71%
20172017-12-310.60−0.28−31.93%
20162016-12-310.88

Gsk current ratio trends

Over the last five fiscal years, Gsk's current ratio decreased from 0.91 to 0.82, a change of −0.10. The latest reported quarter, Q2 2026, shows 0.82.

About the metric

What the current ratio means

The current ratio compares short-term assets with obligations due within roughly one year. A higher ratio generally indicates more short-term balance-sheet coverage, but normal levels vary by industry and business model.

Calculation and source

How the current ratio is calculated

TickerStat calculates the current ratio as SEC-reported current assets divided by SEC-reported current liabilities for the same balance-sheet date. Periods without a positive current-liability value are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Gsk source filings ↗

Community posts

It’s quiet here.

No posts about GSK yet. Start the conversation.

Write the first post